Raquel Mackenzie
Family · Philadelphia, PANPI 1902556483
Payments from drug & device makers
Across 213 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$964
- Teva Pharmaceuticals USA, Inc.$647
- AstraZeneca$617
- AbbVie$588
- Novo Nordisk$519
- GSK$257
- plus $1K from 21 others
What the payments were for
- Consulting fees$1754%
- Speaking & faculty fees$230%
- Food & beverage$4,58192%
- Education$1874%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 38 | $964 |
| Teva Pharmaceuticals USA, Inc. | 25 | $647 |
| AstraZeneca | 21 | $617 |
| AbbVie | 30 | $588 |
| Novo Nordisk | 25 | $519 |
| GSK | 9 | $257 |
| Lilly USA, LLC | 10 | $198 |
| Exact Sciences | 10 | $189 |
| Otsuka America Pharmaceutical, Inc. | 3 | $165 |
| Johnson & Johnson | 6 | $155 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $152 |
| Pfizer | 8 | $129 |
| Dexcom, Inc. | 2 | $71 |
| Amarin Pharma, Inc. | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Medicure Pharma Inc. | 1 | $23 |
| Novartis | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $18 |
| Verona Pharma, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Merck | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,967 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $1,225 |
| Atorvastatin Calcium | 22 | $337 |
| Levothyroxine Sodium | 12 | $180 |
Paid to pharmacies, not to this prescriber.
Other family in Philadelphia
- Bethany ThomasPhiladelphia$126K
- Anne CalvaresiPhiladelphia$81K
- Bethany MooneyPhiladelphia$73K
- Susan Estrella-EadesPhiladelphia$61K
- Michelle Vega-OlivoPhiladelphia$55K
- Danielle LandPhiladelphia$48K
- Nicole SmithPhiladelphia$37K
- Dana SerafinPhiladelphia$31K
- Tammaris KaschakPhiladelphia$27K
- Laura NoltePhiladelphia$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.